HTRA1 and osteoarthritis: Notwithstanding, the herein described potent and selective CKP inhibitors, which also inhibit mouse HTRA1, may serve as valuable tools to further investigate HTRA1 biology and could have other pharmacological applications in HTRA1-associated diseases, such as osteoarthritis and osteoporosis.